The biology of the ABCA3 lipid transporter in lung health and disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28025703)

Published in Cell Tissue Res on December 26, 2016

Authors

Michael F Beers1, Surafel Mulugeta2

Author Affiliations

1: Pulmonary, Allergy, and Critical Care Division, Department of Medicine, Surfactant Biology Laboratories, University of Pennsylvania Perelman School of Medicine, Edward J. Stemmler Hall, Suite 218, 3450 Hamilton Walk, Philadelphia, PA 19104, USA.
2: Pulmonary, Allergy, and Critical Care Division, Department of Medicine, Surfactant Biology Laboratories, University of Pennsylvania Perelman School of Medicine, Edward J. Stemmler Hall, Suite 218, 3450 Hamilton Walk, Philadelphia, PA 19104, USA. mulugeta@mail.med.upenn.edu.

Articles cited by this

(truncated to the top 100)

Intracellular functions of N-linked glycans. Science (2001) 8.39

A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature (1986) 5.77

Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell (1993) 4.66

ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med (2004) 4.64

Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med (2005) 4.25

Pathogenesis and treatment of sickle cell disease. N Engl J Med (1997) 4.04

The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res (2001) 3.95

Modifier genes in mice and humans. Nat Rev Genet (2001) 3.31

Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A (2000) 3.17

Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem (1996) 3.07

Type 2 alveolar cells are stem cells in adult lung. J Clin Invest (2013) 2.93

Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones (1996) 2.80

Management of sickle cell disease. N Engl J Med (1999) 2.73

ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med (2005) 2.52

Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. Am J Physiol Cell Physiol (2000) 2.48

Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1997) 2.42

Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am J Physiol Lung Cell Mol Physiol (2008) 2.39

Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J (2004) 2.26

Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol (2003) 2.20

N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol (2007) 2.06

Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax (1995) 2.04

Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet (2005) 1.97

Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem (2002) 1.92

Molecular and cellular processing of lung surfactant. FASEB J (1994) 1.79

Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol (2009) 1.77

ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett (2001) 1.71

Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. Am J Physiol Cell Physiol (2001) 1.68

Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol (2005) 1.65

Derivation of type 1 epithelium from type 2 cells in the developing rat lung. Lab Invest (1975) 1.65

ABCA3 as a lipid transporter in pulmonary surfactant biogenesis. J Biol Chem (2007) 1.54

ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. J Pediatr (2007) 1.52

Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax (2007) 1.52

Structure and function of ABC transporters. Physiology (Bethesda) (2007) 1.52

Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem (2006) 1.49

Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative. J Cell Sci (2003) 1.44

ABCA3 is critical for lamellar body biogenesis in vivo. J Biol Chem (2007) 1.41

Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res (2007) 1.39

Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res (2006) 1.37

ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res (2006) 1.35

Population and disease-based prevalence of the common mutations associated with surfactant deficiency. Pediatr Res (2008) 1.35

ABC A-subfamily transporters: structure, function and disease. Biochim Biophys Acta (2006) 1.33

Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med (2006) 1.30

Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells. Respir Res (2011) 1.28

Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1994) 1.27

Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage. J Clin Invest (1981) 1.25

Correctors of protein trafficking defects identified by a novel high-throughput screening assay. Chembiochem (2007) 1.24

Defective surfactant secretion in a mouse model of Hermansky-Pudlak syndrome. Am J Respir Cell Mol Biol (2005) 1.23

Usual interstitial pneumonia in an adolescent with ABCA3 mutations. Chest (2008) 1.23

Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Am J Respir Crit Care Med (2014) 1.23

Paediatric interstitial lung disease: classification and definitions. Paediatr Respir Rev (2011) 1.21

The ATP-binding cassette family: a structural perspective. Cell Mol Life Sci (2009) 1.21

Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol (1991) 1.20

Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles. Biochem Biophys Res Commun (2004) 1.20

Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol Chem (2006) 1.20

Surfactant phospholipids: synthesis and storage. Am J Physiol (1992) 1.20

Single ABCA3 mutations increase risk for neonatal respiratory distress syndrome. Pediatrics (2012) 1.18

Identical mutations and phenotypic variation. Hum Genet (1997) 1.16

ABCA3-mediated choline-phospholipids uptake into intracellular vesicles in A549 cells. FEBS Lett (2007) 1.13

Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet (2011) 1.12

Cell turnover in pulmonary tissues. Nature (1962) 1.12

Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. Chest (2010) 1.12

An intronic ABCA3 mutation that is responsible for respiratory disease. Pediatr Res (2012) 1.11

Generation and characterization of monoclonal antibodies to alveolar type II cell lamellar body membrane. Am J Physiol (1998) 1.11

Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J (1997) 1.09

Primary structure of a novel ABC transporter with a chromosomal localization on the band encoding the multidrug resistance-associated protein. FEBS Lett (1996) 1.08

Membrane topology of human ABC proteins. FEBS Lett (2005) 1.07

Expression of pulmonary surfactant protein D in rat gastric mucosa. Am J Respir Cell Mol Biol (1995) 1.06

High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci U S A (2012) 1.06

Trafficking of newly synthesized surfactant protein A in isolated rat alveolar type II cells. Am J Respir Cell Mol Biol (1998) 1.05

Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung disease. Acta Paediatr (2007) 1.05

Alveolar type II cells: studies on the mode of release of lamellar bodies. Tissue Cell (1975) 1.04

The lipids of pulmonary surfactant: dynamics and interactions with proteins. Prog Lipid Res (1998) 1.03

The ABCA subfamily--gene and protein structures, functions and associated hereditary diseases. Pflugers Arch (2006) 1.03

Mouse surfactant protein-D. cDNA cloning, characterization, and gene localization to chromosome 14. J Immunol (1995) 1.02

Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease. Am J Physiol Lung Cell Mol Physiol (2008) 1.02

Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene. Pediatr Res (2004) 1.02

Interfacial properties of pulmonary surfactant layers. Adv Colloid Interface Sci (2005) 1.02

Diseases of pulmonary surfactant homeostasis. Annu Rev Pathol (2015) 1.01

Degradation of surfactant protein D by alveolar macrophages. Am J Physiol (1998) 1.00

A mouse model to test the in vivo efficacy of chemical chaperones. J Pharmacol Toxicol Methods (1998) 0.99

Clearance and recycling of pulmonary surfactant. Am J Physiol (1990) 0.97

Degradation of surfactant lipids and surfactant protein A by alveolar macrophages in vitro. Am J Physiol (1995) 0.97

The cloning of a human ABC gene (ABC3) mapping to chromosome 16p13.3. Genomics (1997) 0.96

Sickle cell disease: no longer a single gene disorder. Curr Opin Pediatr (2001) 0.95

ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. Semin Perinatol (2006) 0.95

ABCA3 Deficiency: an unusual cause of respiratory distress in the newborn. Ulster Med J (2009) 0.94

Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations. Eur Respir J (2013) 0.93

Exclusion of fluid lipid during compression of monolayers of mixtures of dipalmitoylphosphatidylcholine with some other phosphatidylcholines. Biochim Biophys Acta (1981) 0.93

Phenylbutyric acid rescues endoplasmic reticulum stress-induced suppression of APP proteolysis and prevents apoptosis in neuronal cells. PLoS One (2010) 0.93

Recycling of surfactant lipid and apoprotein-A studied by electron microscopic autoradiography. Am J Physiol (1993) 0.87

The Witschi Hypothesis revisited after 35 years: genetic proof from SP-C BRICHOS domain mutations. Am J Physiol Lung Cell Mol Physiol (2013) 0.87

Respiratory syncytial virus potentiates ABCA3 mutation-induced loss of lung epithelial cell differentiation. Hum Mol Genet (2012) 0.87

The human ortholog of the rodent testis-specific ABC transporter Abca17 is a ubiquitously expressed pseudogene (ABCA17P) and shares a common 5' end with ABCA3. BMC Mol Biol (2006) 0.87

Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation. Mod Pathol (2007) 0.87

Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies. Biochem Biophys Res Commun (2007) 0.87

Degradation of dipalmitoyl phosphatidylcholine by isolated rat granular pneumocytes and reutilization for surfactant synthesis. J Clin Invest (1987) 0.86

Surfactant protein A is degraded by alveolar macrophages. Am J Physiol (1996) 0.86

Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. Chem Phys Lipids (2014) 0.85

Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers. Am J Respir Crit Care Med (2009) 0.85

Surface-expressed lamellar body membrane is recycled to lamellar bodies. Am J Physiol Lung Cell Mol Physiol (2000) 0.85